Clinical Trials
2 trialsNCT04841811 2026-05-22
APPROACH
Guangdong Association of Clinical Trials
Phase 3 Active not recruiting
NCT07183189 2026-04-14
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Recruiting